Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

A cost-effectiveness analysis of the Chlamydia Monday--a community-based intervention to decrease the prevalence of chlamydia in Sweden.

Deogan CL, Bocangel MK, Wamala SP, Månsdotter AM.

Scand J Public Health. 2010 Mar;38(2):141-50. doi: 10.1177/1403494809357260. Epub 2010 Jan 11.

PMID:
20064921
2.

Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis.

Hu D, Hook EW 3rd, Goldie SJ.

Ann Intern Med. 2004 Oct 5;141(7):501-13. Erratum in: Ann Intern Med. 2004 Nov 2;141(9):744.

PMID:
15466767
3.
4.

The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.

Gift TL, Gaydos CA, Kent CK, Marrazzo JM, Rietmeijer CA, Schillinger JA, Dunne EF.

Sex Transm Dis. 2008 Nov;35(11 Suppl):S66-75. doi: 10.1097/OLQ.0b013e31818b64ac.

PMID:
18830137
5.

The cost effectiveness of screening for genital Chlamydia trachomatis infection in Australia.

Walleser S, Salkeld G, Donovan B.

Sex Health. 2006 Dec;3(4):225-34.

PMID:
17112432
6.

An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.

Norman JE, Wu O, Twaddle S, Macmillan S, McMillan L, Templeton A, McKenzie H, Noone A, Allardice G, Reid M.

BJOG. 2004 Nov;111(11):1261-8.

7.
8.

A Swedish cost-effectiveness analysis of community-based Chlamydia trachomatis PCR testing of postal urine specimens obtained at home.

Novak DP, Lindholm L, Jonsson M, Karlsson RB.

Scand J Public Health. 2004;32(5):324-32.

PMID:
15513664
9.

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection.

Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, Horner P, Skidmore S, Sterne JA, Sanford E, Ibrahim F, Holloway A, Patel R, Barton PM, Robinson SM, Mills N, Graham A, Herring A, Caul EO, Davey Smith G, Hobbs FD, Ross JD, Egger M; Chlamydia Screening Studies Project Group..

Health Technol Assess. 2007 Mar;11(8):iii-iv, ix-xii, 1-165. Review.

10.

Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.

Blake DR, Gaydos CA, Quinn TC.

Sex Transm Dis. 2004 Feb;31(2):85-95.

PMID:
14743071
11.

A model for cost-effectiveness analyses of smoking cessation interventions applied to a Quit-and-Win contest for mothers of small children.

Johansson PM, Tillgren PE, Guldbrandsson KA, Lindholm LA.

Scand J Public Health. 2005;33(5):343-52.

PMID:
16265801
12.

Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis.

Postma MJ, Welte R, van den Hoek JA, van Doornum GJ, Jager HC, Coutinho RA.

Value Health. 2001 May-Jun;4(3):266-75.

PMID:
11705188
13.

The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.

Gillespie P, O'Neill C, Adams E, Turner K, O'Donovan D, Brugha R, Vaughan D, O'Connell E, Cormican M, Balfe M, Coleman C, Fitzgerald M, Fleming C.

Sex Transm Infect. 2012 Apr;88(3):222-8. doi: 10.1136/sextrans-2011-050067. Epub 2012 Jan 2.

PMID:
22213681
14.

Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach.

Welte R, Kretzschmar M, Leidl R, van den Hoek A, Jager JC, Postma MJ.

Sex Transm Dis. 2000 Oct;27(9):518-29.

PMID:
11034526
15.
16.

Developments in the screening for Chlamydia trachomatis: a review.

Kohl KS, Markowitz LE, Koumans EH.

Obstet Gynecol Clin North Am. 2003 Dec;30(4):637-58. Review.

PMID:
14719842
17.

[Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].

Postma MJ, Welte R, van den Hoek JA, van Doornum GJ, Coutinho RA, Jager JC.

Ned Tijdschr Geneeskd. 1999 Mar 27;143(13):677-81. Dutch.

PMID:
10321301
18.

A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration.

Karnon J, Czoski-Murray C, Smith K, Brand C, Chakravarthy U, Davis S, Bansback N, Beverley C, Bird A, Harding S, Chisholm I, Yang YC.

Health Technol Assess. 2008 Jun;12(27):iii-iv, ix-124.

19.

Chlamydia trachomatis screening in family planning centers: a review of cost/benefit evaluations in different countries.

Henry-Suchet J, Sluzhinska A, Serfaty D.

Eur J Contracept Reprod Health Care. 1996 Dec;1(4):301-9. Review.

PMID:
9678112
20.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

Supplemental Content

Support Center